756520-72-6

Usage

Uses

Used in Organic Synthesis:
4-(1,1-Dioxido-2-isothiazolidinyl)phenylboronic Acid Pinacol Ester is used as a reagent in organic synthesis for its ability to bind to certain molecules and facilitate various chemical reactions. Its boronic acid functional group plays a crucial role in this application, enabling the formation of new compounds and the modification of existing ones.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-(1,1-Dioxido-2-isothiazolidinyl)phenylboronic Acid Pinacol Ester is used as a research tool to explore its potential in drug discovery and development. Its unique structure and properties make it an interesting target for further investigation, with the aim of identifying new therapeutic agents and improving existing ones.
Used in Chemical Sciences:
4-(1,1-Dioxido-2-isothiazolidinyl)phenylboronic Acid Pinacol Ester is also used in the field of chemical sciences to study its properties and behavior in different chemical environments. This research can lead to a better understanding of the compound and its potential applications in various chemical processes and reactions.

Upstream product

• 1633-82-5 3-chloro-n-propanesulfonyl chloride 
• 214360-73-3 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)aniline 
• 71703-16-7 2-(4-bromophenyl)-1,2-thiazolidine-1,1-dioxide 
• 73183-34-3 bis(pinacol)diborane 

Relevant academic research and scientific papers

MAP4K4 INHIBITORS

This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, f

HETEROARYL SYK INHIBITORS

The invention relates to new substituted heteroarylsof formula (1) wherein A is selected from the group consisting of N and CH, D is selected from the group consisting of S and O, E is C, T is C, G is C, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.

SPIROPIPERIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHERMER’S DISEASE

The present invention is directed to spiropiperidine compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. T

AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS

Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.